|
⚲
|
| Keyboard |
| Jonathan Tunnicliffe | |
|---|---|
| Firm | NovaQuest Capital Management LLC |
| Address | c/o NovaQuest Capital Management, LLC 4208 Six Forks Road, Suite 920 Raleigh, NC 27609 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| NovaQuest Capital Management LLC | |||||
| NovaQuest Pharma Opportunities Fund VI Aggregator LP | 021-479248 | Director | 90.0 M of 800.0 M |
10.8 M | |
| NovaQuest Pharma Opportunities Fund VI LP | 021-479248 | Director | 90.0 M of 800.0 M |
73.9 M | |
| NovaQuest Animal Health Opportunities Fund Delaware LP | 021-421813 | Director | 80.6 M of 250.0 M |
140.8 M | |
| NovaQuest Animal Health Opportunities Fund LP | 021-421813 | Director | 80.6 M of 250.0 M |
10.3 M | |
| NovaQuest Animal Health Opportunities Fund Delaware LP | 021-421815 | Director | 80.6 M of 250.0 M |
||
| Revance Therapeutics Inc | 021-205127 | Director | 10.0 M of 30.0 M |
||
| Revance Therapeutics Inc | 021-192272 | Director | 5.0 M of 60.0 M |
||
| Revance Therapeutics Inc | 021-154773 | Director | 63.4 M of 63.4 M |
||